NO-flurbiprofen reduces amyloid-β, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade

Selective modulation of amyloid-β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels

(2009) Samer O. Abdul-Hay et al.   JOURNAL OF NEUROCHEMISTRY

Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort

(2009) J.C.S. Breitner et al.   NEUROLOGY

The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action

(2008) Aymen I. Idris et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

(2008) Gordon K Wilcock et al.   LANCET NEUROLOGY

Anti-Inflammatory, Antiproliferative, and Cytoprotective Activity of NO Chimera Nitrates of Use in Cancer Chemoprevention

(2008) G. K. Hagos et al.   MOLECULAR PHARMACOLOGY

The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics

(2008) Jon O. Lundberg et al.   NATURE REVIEWS DRUG DISCOVERY

No advantage of A 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

(2008) C. A. Szekely et al.   NEUROLOGY

Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults

(2008) Elizabeth Thomas et al.   NEUROPSYCHOLOGIA